Title: Drug Discovery in Large Pharma: Fundamentals and Future
This seminar will cover the following topics:
What is large pharma and how did it get that way?
What does it take to discover a drug candidate and get it into clinical trials, and why?
Horror stories: Learning from failure
How has pharma responded to the R&D productivity crisis?
The future of drug discovery: will AI save the day?
Patrick Story, PhD | Principal Consultant for Leaping Cat Pharma Solutions
About Dr. Story:
Patrick Stoy is a leader in drug discovery with 15 years pharma R&D experience at GlaxoSmithKline and Bristol-Myers Squibb. As a scientist, team leader, and research director he has helped discover several first-in-class clinical drug candidates in the cardiovascular, respiratory, oncology and inflammation therapeutic areas. His expertise is in creating and optimizing small molecule drug candidates, building and leading high performing scientific teams, applying modern design methods and platforms, and early portfolio management. Patrick is a third-generation organic chemist with a deep background in synthetic and medicinal chemistry. His particular passion is applying High Velocity Edge principles to accelerate drug discovery and development. Patrick is currently Principal Consultant at Leaping Cat Pharma Solutions LLC in the Denver, CO area and is a SPARK Advisor for CU Innovations / Anschutz.